Phase Holographic Imaging PHI AB (publ) (PHI.ST)

7,80 -0,34 (-4,18%) In data: 09:46AM CEST. Mercato aperto.

Phase Holographic Imaging PHI AB (publ)

SkiffervAegen 48
Lund 224 78
Sweden
46 46 38 60 80
https://www.phiab.se

Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 13

Figure dirigenziali chiave

Nome	Titolo	Retribuzione	Esercitate	Anno di nascita
Mr. Patrik Eschricht	Chief Executive Officer	N/D	N/D	1964
Mr. Håkan Rosvall	President	N/D	N/D	1979
Mr. Peter Egelberg	Founder, Head of Sales & Marketing and Director	N/D	N/D	1963
Mr. Jonas Bergkvist	Chief Technology Officer	N/D	N/D	1971
Ms. Kersti Alm	Chief Scientist	N/D	N/D	N/D
Ms. Lisa Bodily	Head of Digital Marketing & Communication	N/D	N/D	N/D

Gli importi risalgono al giorno e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in SEK.

Descrizione

Phase Holographic Imaging PHI AB (publ) develops and markets instrumentation for non-invasive time-lapse imaging in Sweden and internationally. The company's products include HoloMonitor M4, a live cell imaging microscope system; HoloMonitor M3, a bench-top time-lapse cytometer equipped with a motorized stage and variable magnification; HoloMonitor app Suite for cell imaging software facilitates kinetic live-cell tracking and analysis; HoloMonitor M4FL, a system for fluorescence; and HoloMonitor single tracking, kinetic dose response and cell mobility, cell morphology, wound healing, cell quality control, cell control, and kinetic cell proliferation assay. It offers HoloLids to eliminate image disturbances caused by surface vibrations and condensation inside the cell culture vessel; Vessel Holder to fix the culture vessel to the motorized stage; and HoloDry to keep optics for condensation of HoloMonitor free. Its products are used in cancer research, drug discovery and development, single cell analysis, cell counting, cell quality check, counting, proliferation, motility, migration, morphology, and tracking, as well as dose responses and wound healing. The company was incorporated in 1997 and is based in Lund, Sweden.

Governance aziendale

L'ISS Governance QualityScore di Phase Holographic Imaging PHI AB (publ) al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.